» Articles » PMID: 38921360

Assessing Diagnosis of Infections: A Study on Species Prevalence and Antifungal Resistance in Northern Morocco

Overview
Journal J Fungi (Basel)
Date 2024 Jun 26
PMID 38921360
Authors
Affiliations
Soon will be listed here.
Abstract

The incidence of infections has increased in the last decade, posing a serious threat to public health. Appropriately facing this challenge requires precise epidemiological data on species and antimicrobial resistance incidence, but many countries lack appropriate surveillance programs. This study aims to bridge this gap for Morocco by identifying and phenotyping a year-long collection of clinical isolates (n = 93) from four clinics in Tetouan. We compared the current standard in species identification with molecular methods and assessed susceptibility to fluconazole and anidulafungin. Our results identified limitations in currently used diagnostics approaches, and revealed that ranks as the most prevalent species with 60 strains (64.52%), followed by with 14 (15.05%), with 6 (6.45%), and with 4 (4.30%). In addition, we report the first identification of in Morocco. Susceptibility results for fluconazole revealed that some isolates were approaching MICs resistance breakpoints in (2), and (1). Our study also identified anidulafungin resistant strains in (1), (1), and (2), rendering the two strains from the latter species multidrug-resistant due to their innate resistance to fluconazole. These results raise concerns about species identification and antifungal resistance in Morocco and highlight the urgent need for more accurate methods and preventive strategies to combat fungal infections in the country.

Citing Articles

Insights into the origin, hybridisation and adaptation of Candida metapsilosis hybrid pathogens.

Del Olmo V, Redondo-Rio A, Garcia A, Limtong S, Saus E, Gabaldon T PLoS Pathog. 2025; 21(1):e1012864.

PMID: 39823524 PMC: 11781744. DOI: 10.1371/journal.ppat.1012864.


Threats from the complex: the surge of multidrug resistance and a hotbed for new emerging pathogens.

Gabaldon T Microbiol Mol Biol Rev. 2024; 88(4):e0002923.

PMID: 39508581 PMC: 11653726. DOI: 10.1128/mmbr.00029-23.

References
1.
Ghelardi E, Pichierri G, Castagna B, Barnini S, Tavanti A, Campa M . Efficacy of Chromogenic Candida Agar for isolation and presumptive identification of pathogenic yeast species. Clin Microbiol Infect. 2007; 14(2):141-7. DOI: 10.1111/j.1469-0691.2007.01872.x. View

2.
Hospenthal D, Beckius M, Floyd K, Horvath L, Murray C . Presumptive identification of Candida species other than C. albicans, C. krusei, and C. tropicalis with the chromogenic medium CHROMagar Candida. Ann Clin Microbiol Antimicrob. 2006; 5:1. PMC: 1334214. DOI: 10.1186/1476-0711-5-1. View

3.
Perlin D . Echinocandin Resistance in Candida. Clin Infect Dis. 2015; 61 Suppl 6:S612-7. PMC: 4643482. DOI: 10.1093/cid/civ791. View

4.
Mixao V, Carlos Nunez-Rodriguez J, Del Olmo V, Ksiezopolska E, Saus E, Boekhout T . Evolution of loss of heterozygosity patterns in hybrid genomes of Candida yeast pathogens. BMC Biol. 2023; 21(1):105. PMC: 10173528. DOI: 10.1186/s12915-023-01608-z. View

5.
Carrillo-Munoz A, Giusiano G, Ezkurra P, Quindos G . Antifungal agents: mode of action in yeast cells. Rev Esp Quimioter. 2006; 19(2):130-9. View